drugset / Trial / NCT04021238
Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine if contrast-enhanced ultrasound can detect abnormal features of kidney lesions in patients with suspected kidney cancer with the same accuracy as conventional ultrasound and contrast-enhanced magnetic resonance imaging (MRI)
Timeline
- Start
- 2020-10-07
- Primary completion
- 2022-08-05
- Completion
- 2022-08-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Definity | Diagnostic / imaging agent | — | Intravenous |
| Subject | Lumason | Diagnostic / imaging agent | — | Intravenous |